Trending NewsTrending NewsNYSE:DOCS Doximity (DOCS) Stock Price, News & Analysis $26.56 +0.62 (+2.37%) Closing price 03:59 PM EasternExtended Trading$26.64 +0.08 (+0.31%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOwnershipSEC FilingsShort Interest About Doximity Stock (NYSE:DOCS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Doximity alerts:Sign Up Key Stats Today's Range$25.56▼$26.6150-Day Range$20.42▼$27.3552-Week Range$17.15▼$76.51Volume2.17 million shsAverage Volume4.07 million shsMarket Capitalization$4.73 billionP/E Ratio31.24Dividend YieldN/APrice Target$32.18Consensus RatingHold Company Overview Doximity, Inc. operates a digital platform for U.S. medical professionals. Its network enables physicians and other healthcare providers to communicate, collaborate, access medical news and research, maintain professional profiles, and connect with colleagues and patients. The company offers a range of tools for healthcare organizations and professionals, including telehealth services, digital faxing, scheduling and communication products, and solutions for recruiting and marketing. Doximity also provides pharmaceutical and healthcare companies with digital engagement services designed to reach medical professionals through its platform. Founded in 2010, Doximity is headquartered in San Francisco and primarily serves the United States healthcare market. The company was co-founded by Jeff Tangney, who serves as chief executive officer, along with Nate Gross and Shari Buck.AI Generated. May Contain Errors. Read More Doximity Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks89th Percentile Overall ScoreDOCS MarketRank™: Doximity scored higher than 89% of companies evaluated by MarketBeat, and ranked 32nd out of 900 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.9 / 5Analyst RatingHold Consensus RatingDoximity has received a consensus rating of Hold. The company's average rating score is 2.31, and is based on 2 strong buy ratings, 7 buy ratings, 14 hold ratings, and 3 sell ratings.Upside PotentialDoximity has a consensus price target of $32.18, representing about 21.3% upside from its current price of $26.53.Amount of Analyst CoverageDoximity has been the subject of 13 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Doximity's stock forecast and price target. Earnings and Valuation3.1 / 5Proj. Earnings Growth28.38% Earnings GrowthEarnings for Doximity are expected to grow by 28.38% in the coming year, from $0.74 to $0.95 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Doximity is 31.20, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.00.Price to Earnings Ratio vs. SectorThe P/E ratio of Doximity is 31.20, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.15.Price to Earnings Growth RatioDoximity has a PEG Ratio of 20.19. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioDoximity has a P/B Ratio of 5.11. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted11.55% of the float of Doximity has been sold short.Short Interest Ratio / Days to CoverDoximity has a short interest ratio ("days to cover") of 4.98.Change versus previous monthShort interest in Doximity has recently decreased by 23.80%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldDoximity does not currently pay a dividend.Dividend GrowthDoximity does not have a long track record of dividend growth. News and Social Media2.2 / 5News Sentiment0.50 News SentimentDoximity has a news sentiment score of 0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.79 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 15 news articles for Doximity this week, compared to 6 articles on an average week.Search InterestOnly 9 people have searched for DOCS on MarketBeat in the last 30 days. This is a decrease of -40% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Doximity to their MarketBeat watchlist in the last 30 days. This is a decrease of -80% compared to the previous 30 days. Company Ownership2.1 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Doximity insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $441,412.00 in company stock.Percentage Held by Insiders31.80% of the stock of Doximity is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions87.19% of the stock of Doximity is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Doximity's insider trading history. Receive DOCS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Doximity and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. DOCS Stock News HeadlinesDOXIMITY, INC. (DOCS) INVESTOR ALERT Investors With Large Losses in Doximity, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights25 minutes ago | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Doximity, Inc. of Class Action Lawsuit and Upcoming Deadlines - DOCS30 minutes ago | prnewswire.comALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.September 17 at 1:00 AM | Weiss Ratings (Ad)DOCS Shareholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Doximity, Inc.1 hour ago | prnewswire.comDOCS INVESTOR ALERT: Doximity, Inc. Investors with Substantial Losses Have Opportunity to Lead the Doximity Class Action Lawsuit1 hour ago | prnewswire.comDOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit with SBS Law3 hours ago | businesswire.comDoximity (NYSE:DOCS) CAO Sells $54,043.54 in StockSeptember 17 at 7:22 AM | insidertrades.comDoximity (NYSE:DOCS) CAO Sells 1,770 Shares of StockAugust 18, 2026 | insidertrades.comSee More Headlines DOCS Stock Analysis - Frequently Asked Questions How have DOCS shares performed this year? Doximity's stock was trading at $44.26 at the beginning of the year. Since then, DOCS stock has decreased by 40.1% and is now trading at $26.5320. How were Doximity's earnings last quarter? Doximity, Inc. (NYSE:DOCS) posted its quarterly earnings data on Thursday, August, 6th. The company reported $0.29 earnings per share for the quarter, topping analysts' consensus estimates of $0.16 by $0.13. The business's revenue was up 7.3% compared to the same quarter last year. Read the conference call transcript. How will Doximity's stock buyback program work? Doximity's board approved a stock buyback plan on Thursday, February 5th 2026, which permits the company to repurchase $500,000,000 in shares, according to EventVestor. This means that the company could repurchase up to 8% of its stock through open market purchases. Stock buyback plans are usually a sign that the company's board believes its stock is undervalued. When did Doximity IPO? Doximity (DOCS) raised $501 million in an initial public offering on Thursday, June 24th 2021. The company issued 23,300,000 shares at $20.00-$23.00 per share. Morgan Stanley, Goldman Sachs and J.P. Morgan Securities served as the underwriters for the IPO and Piper Sandler, William Blair, Canaccord and Raymond James were co-managers. Who are Doximity's major shareholders? Doximity's top institutional investors include Wellington Management Group LLP (1.76%), Carmignac Gestion (1.32%), Fundsmith LLP (0.37%) and Engineers Gate Manager LP (0.16%). Insiders that own company stock include Anna Bryson, Craig Overpeck, Siddharth Sitaram, Regina M Benjamin, Kira Scherer Wampler, Watkin Phoebe L Yang and Timothy S Cabral. View institutional ownership trends. How do I buy shares of Doximity? Shares of DOCS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Doximity own? Based on aggregate information from My MarketBeat watchlists, some other companies that Doximity investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Tesla (TSLA), CrowdStrike (CRWD), PayPal (PYPL) and Invesco QQQ (QQQ). Company Calendar Last Earnings8/06/2026Today9/17/2026Fiscal Year End3/31/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 DOCS's financial health is in the Green zone, according to TradeSmith. DOCS has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Healthcare Technology Sub-IndustryHealthcare Technology Current SymbolNYSE:DOCS Previous SymbolNASDAQ:DOCS CIK1516513 Webdoximity.com Phone(650) 549-4330FaxN/AEmployees880Year Founded2010Price Target and Rating Average Price Target for Doximity$32.18 High Price Target$65.00 Low Price Target$18.00 Potential Upside/Downside+21.2%Consensus RatingHold Rating Score (0-4)2.31 Research Coverage26 Analysts Profitability EPS (Trailing Twelve Months)$0.85 Trailing P/E Ratio31.24 Forward P/E Ratio35.89 P/E Growth20.19Net Income$196.05 million Net Margins25.48% Pretax Margin34.51% Return on Equity18.06% Return on Assets15.40% Debt Debt-to-Equity RatioN/A Current Ratio6.08 Quick Ratio6.08 Sales & Book Value Annual Sales$644.86 million Price / Sales7.34 Cash Flow$1.28 per share Price / Cash Flow20.82 Book Value$5.19 per share Price / Book5.12Miscellaneous Outstanding Shares178,250,000Free Float121,564,000Market Cap$4.73 billion OptionableN/A Beta1.25 Social Links 7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free Report This page (NYSE:DOCS) was last updated on 9/17/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredYour withdrawal order could cost you in taxesIf you have $2M or more saved, the 4% rule points to roughly $92,000 a year - but it's a single-variable answe...SmartAsset | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Doximity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Doximity With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
